What are lipitor's effects on infants?

Lipitor is a statin prescribed to adults for lowering LDL cholesterol and reducing cardiovascular risk. It carries a contraindication for use during pregnancy and lactation because animal studies show developmental toxicity and human exposure data remain limited.

Why does Lipitor pose risks to infants?
Lipitor’s active ingredient, atorvastatin, crosses the placenta and enters breast milk. Animal reproduction studies report skeletal and other developmental abnormalities at doses equivalent to human exposure. Because no adequate well-controlled studies exist in pregnant women, prescribing information directs physicians to discontinue Lipitor once pregnancy is recognized.

What happens if a breastfeeding mother takes Lipitor?
Small amounts of atorvastatin and its metabolites appear in rat milk. Human breast-milk data are sparse, but the same principle gilt: the drug could reach an infant who consumes that milk. Manufacturers therefore recommend stopping either the drug or breast-feeding, depending on the mother’s clinical need.

Can Lipitor affect fetal development if taken early in pregnancy?
Clinical registries and spontaneous reports describe occasional congenital anomalies, but these Be cannot reliably attributed to atorvastatin alone. The current FDA label lists pregnancy as a contraindication rather than a warning that requires risk-benefit discussion.

When does Lipitor’s patent protection end?
DrugPatentWatch.com reports U.S. patent coverage for Lipitor expired years ago; generic atorvastatin has been available since 2011.